2-chloro-6-vinylbenzoic acid | 1562995-50-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-chloro-6-vinylbenzoic acid
• 英文别名: 2-chloro-6-ethenylbenzoic acid
• CAS: 1562995-50-9
• 化学式: C₉H₇ClO₂
• 分子量: 182.606
• InChiKey: QGASMXNEFJUMFG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  2-溴-6-氯苯甲酸 在 四(三苯基膦)钯 、 水 、 potassium carbonate 、 sodium hydroxide 作用下， 以 1,4-二氧六环 、 乙醇 、 水 为溶剂， 反应 5.0h， 生成 2-chloro-6-vinylbenzoic acid
  参考文献：
  名称：

  [EN] 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
  [FR] COMPOSÉS D'ACIDE BENZOÏQUE SUBSTITUÉS PAR UN 4-HÉTÉROARYLE À TITRE D'INHIBITEURS DE RORGAMMAT ET LEURS UTILISATIONS

  摘要：

  公开号：

  WO2014028589A3

文献信息

• 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
  申请人：Merck Sharp & Dohme Corp.

  公开号：US20150218096A1

  公开（公告）日：2015-08-06

  The present invention relates to compounds according to Formula I (Formula I), and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.

  本发明涉及公式I（公式I）的化合物及其药学上可接受的盐或溶剂。这样的化合物可用于治疗RORgammaT介导的疾病或症状。
• Solvent based coating composition
  申请人：Nippon Paint Co., Ltd.

  公开号：EP0413352A2

  公开（公告）日：1991-02-20

  Disclosed is a solvent based coating composition comprising at least one kind of vinyl polymer and an organic solvent, wherein any one of said vinyl polymer has at least one kind selected from the group consisting of an active hydrogen-containing group and a substituted acylamide group, and said vinyl polymer contains the above described two kinds of group as a whole.

  本发明公开了一种溶剂型涂料组合物，该组合物包含至少一种乙烯基聚合物和一种有机溶剂，其中任一种所述乙烯基聚合物具有至少一种从活性含氢基团和取代的酰酰胺基团组成的组中选出的基团，且所述乙烯基聚合物整体包含上述两种基团。
• Aqueous dispersion coating composition
  申请人：Nippon Paint Co., Ltd.

  公开号：EP0413351A2

  公开（公告）日：1991-02-20

  Disclosed is an aqueous dispersion coating composition comprising at least one kind of resins, wherein any one of said resins has at least one kind selected from the group consisting of an active hydrogen-containing group, a substituted acylamide group and a water dispersible or water-soluble group, and said resin composition contains the above described kinds of group as a whole.

  本发明公开了一种水性分散涂料组合物，该组合物包含至少一种树脂，其中任一种树脂具有至少一种选自活性含氢基团、取代的酰酰胺基团和水分散或水溶性基团组成的组的基团，且所述树脂组合物整体包含上述基团。
• Cationic electrocoating composition
  申请人：NIPPON PAINT CO., LTD.

  公开号：EP0431554A2

  公开（公告）日：1991-06-12

  The present invention provides a cationic electrocoating composition which cures at the preferred curing temperature range and provides superior curing properties and cured film properties. The cationic electrocoating composition of the present invention comprises a resinous component and an aqueous medium, wherein the resinous component is composed of one or more polymers and has as a whole an active hydrogen containing group, a cationic group and a substituted group and at least one of the polymers comprises a vinyl polymer which has 5 to 1,000 substituted acylamide groups.

  本发明提供了一种阳离子电涂层组合物，它能在优选的固化温度范围内固化，并具有优异的固化性能和固化膜性能。本发明的阳离子电涂组合物包括树脂成分和水介质，其中树脂成分由一种或多种聚合物组成，整体上具有活性含氢基团、阳离子基团和取代基团，至少一种聚合物包括乙烯基聚合物，该聚合物具有 5 至 1 000 个取代的酰酰胺基团。
• 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof
  申请人：Merck Sharp & Dohme Corp.

  公开号：US10196354B2

  公开（公告）日：2019-02-05

  The present invention relates to compounds according to Formula I (Formula I), and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.

  本发明涉及根据式 I（式 I）的化合物及其药学上可接受的盐或溶液。此类化合物可用于治疗 RORgammaT 介导的疾病或病症。